Good morning and happy Monday.

We had a nice run of executive interviews on Cultivated Live last week: Luc Mongeau of Canopy Growth, Mike Gorenstein of Cronos Group, and Aaron Miles on Verano. It’s always good to take the industry’s pulse. You can check out all those interviews on our YouTube channel » Later this morning, we’ll welcome Ben Stoller from CannaDots to Cultivated Live »

Let’s get to it.

-JB, JR

Today’s newsletter is 1,233 words or about a 9-minute read.

TODAY’S EDITION MADE POSSIBLE BY:

CULTIVATED CALENDAR

December 2 » Cultivated Subscribers’ Breakfast Las Vegas → Open to all subscribers. Secret Las Vegas location.
December 17 » Cultivated Buffalo powered by Jaunty → Our first event in Western New York. Get tickets today!

Visit our revamped Events Page »

What’s the big deal?

SCHEDULE III
Verano’s net loss shrinks to $4 million on rescheduling tax relief

Verano Holdings narrowed its third-quarter net loss to $4 million from $44 million a year ago, mostly thanks to tax relief from medical rescheduling. Revenue rose 5% to $212 million, all organic. 

With medical at just under 65% of sales, Verano has more riding on rescheduling than most.

“It used to be us trying to quantify it. You could actually see what happened in the quarter,” Verano’s Aaron Miles said on Friday’s Cultivated Live.

Verano is making a timing bet that some of its peers passed on. Recreational hasn’t been rescheduled, so 280E still hits operators that sell both. Glass House and Trulieve split off their medical businesses to capture the relief. 

Verano is holding off, betting full rescheduling arrives soon enough to make a carve-out unnecessary. If it lands in 2026, the bet pays off. If it slips to 2027, Verano gives up a year of savings.

Miles called a Pennsylvania recreational program “a foregone conclusion” now that Democrats control state government. Verano runs 18 dispensaries there.

Watch the full interview:

Quotable

“We have spent the majority of our time over the last six years trying to put the worms back in the can,” Lt. Col. Mitch Smith, of the Oklahoma Bureau of Narcotics and Dangerous Drugs, told the North Carolina Advisory Council on Cannabis’s public safety subcommittee as the state weighs legalization. 

He argued that Oklahoma’s licensing system was far too laissez-faire and the state has spent money and time reining it in. Read the full story.

Premium

The Pitch Deck: Hippy Market

Over the weekend, Cultivated Members got the second edition of our revamped Pitch Deck series, which spotlights cannabis and cannabis tech startups that are raising or just closed a round.

This time it was Hippy Market, founded by Kat Kaneski. Her previous venture, Field Trip Rolling Papers, lost 69% of its wholesale business overnight when mainstream platforms cut off the category, she said. So she built a B2B marketplace for smoking accessories with its own payment rails, basically Faire for products Faire won’t touch.

We talked about why federal legalization won’t fix the payment problem, how two people built the company with AI, and why she sees a payments company as the natural buyer. Cultivated Members also get the full deck.

Upgrade to Premium to see the full pitch deck »

Disclosure: Jeremy invested in Hippy Market’s seed round.

(More) Premium

People Moves for Monday, November 16th

Every Monday, Cultivated Members get a glimpse of who’s moving up, who’s moving on, and who is hiring across the cannabis industry.

We believe it’s the most comprehensive, weekly list of its kind.

You can get it in your inbox every Monday if you become a Cultivated Member »

This week, you would learn that Canopy Growth has hired a new Business Development Manager based in Germany and that the Virginia Cannabis Control Authority is seeking four Financial Compliance Analysts/Auditors, plus much, much more.

Insights

LIT ALERTS*
New York’s bulk boom: Ounces now cost 55.7% less per gram than eighths

Lit Alerts’ November Retail Price Index for New York is out, and the shelf data keeps pointing the same direction: bigger formats, lower prices, faster volume.

A full ounce now averages $4.60 per gram, versus $10.39 for an eighth. Half-ounce volume jumped 26.8% in six months. 2g concentrates fell 13.9% but saw unit sales surge 85%, while 0.5g vape carts slid 11.3% as volume dropped 21.3%.

The oddities persist, too.

A 2.5g pre-roll pack still costs more than a 3.5g pack, and a 50mg edible still costs more than a 100mg one.

Two products refuse to budge: 1g pre-rolls ($12.88) and 10mg beverages ($5.39), both with volume up more than 20%.

*sponsored

Quick hits

Maryland moves hemp behind the dispensary counter

The Maryland Cannabis Administration told dispensaries that starting Dec. 11, only hemp products that meet the new federal definition can be sold in public waiting areas. Everything else, including products over the federal cap of 0.4 milligrams of THC per container, can still be sold from restricted service areas if it passes state testing, packaging and labeling rules.

Massachusetts advances first testing overhaul since cannabis regulator’s founding

The Cannabis Control Commission advanced draft rules Thursday that would require labs to automatically retest failed samples before issuing results and require product labels to say whether a product was remediated. The rules also require testing before any sale and eliminate the Standards Laboratory license. Final approval is expected in December, and the rules would take effect about April 2027.

Texas’ incoming leaders put THC regulation on 2027 agenda

Lt. Gov.-elect Vikki Goodwin, who unseated Dan Patrick, said regulating THC is among the priorities getting the Senate’s first 30 bill numbers, and that she is “not interested in a full ban on THC.” Agriculture Commissioner-elect Clayton Tucker said “hemp, I think, is going to be our saving grace” for farmers, pointing to how well the crop handles drought.

Cultivated Live

On Friday’s Cultivated Live, we dug into Glass House’s 90% slide since its NYSE debut and what it tells the big exchanges and institutional investors about cannabis. We also broke down our interviews with Organigram and Cronos to wrap up earnings week.

Science & research

Medical cannabis patients twice as likely to quit opioids, New York study finds

Chronic pain patients on long-term opioids who used medical cannabis for more than 30 days stopped their opioid prescriptions at twice the rate of those who didn’t, 15.5% vs. 7.6%, according to a study of 8,358 New York patients in the Journal of Addiction Medicine. The effect was strongest in the first month for patients on lower opioid doses and disappeared entirely for those at the highest doses.

Earnings roundup

Ascend Wellness Holdings reported $130 million in Q3 revenue, up 4.2% from a year ago, and plans to bring products to Canada in early 2027 through a licensing deal. $AAWH ( ▼ 2.64% )

Grown Rogue reported $11 million in Q3 revenue, up 29% from a year ago, and swung to an $8.9 million net loss. $GRIN.CSE ( 0.0% ) $GRUSF ( ▼ 5.05% )

IM Cannabis reported a 67% drop in Q3 revenue to C$1.65 million after selling its German business, and is negotiating a non-binding deal to buy a majority stake in a Polish drone maker. $IMCC ( ▼ 4.96% )

What we’re reading

What did you think of today's Cultivated Daily?

Login or Subscribe to participate